Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States

This publication has 23 references indexed in Scilit:

• Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis
  Pediatrics, 2000
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
  The Pediatric Infectious Disease Journal, 2000
• The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
  The Journal of Infectious Diseases, 1999
• Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory
  The Journal of Infectious Diseases, 1999
• Meningococcal Disease and Public Health Practice: A Complicated Road Map
  Published by American Medical Association (AMA) ,1998
• Induction of Immunologic Memory in Gambian Children by Vaccination in Infancy with a Group A plus Group C Meningococcal Polysaccharide-Protein Conjugate Vaccine
  The Journal of Infectious Diseases, 1997
• Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial
  Published by American Medical Association (AMA) ,1996
• Epidemiology and prevention of meningococcal disease
  The Pediatric Infectious Disease Journal, 1995
• Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines
  The Pediatric Infectious Disease Journal, 1993
• AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINE
  The Lancet, 1985